The Vanguard Group 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

The Vanguard Group 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-09
11:32 am
Purchase		2022-12-3013GSeres Therapeutics, Inc.
MCRB		The Vanguard Group6,092,937
4.890%		1,416,672increase
(+30.29%)		Filing
2022-02-10
08:37 am
Purchase		2021-12-3113GSeres Therapeutics, Inc.
MCRB		The Vanguard Group4,676,265
5.090%		4,676,265increase
(New Position)		Filing